DP Clinical, Inc. is a privately-held, Contract Research Organization (CRO) partnering with all Pharmaceutical, Biotech Companies, and Government Sponsors
📢 FDA Office of Women’s Health advocates for #WomensHealth on all fronts.
Learn more about the research efforts that @FDAWomen funds: https://t.co/4D9erU7DXD
#FDAwomen
Check out the latest FDA Roundup, our at-a-glance summary of agency updates: https://t.co/ciM5yhktV1
On Monday, the FDA approved the first orally disintegrating tablet approved for the prevention of pregnancy. https://t.co/uBVyyftWUY
On Monday, the FDA published common questions received related to laboratory developed tests (LDTs). https://t.co/NL0QKTw7UL
On Monday, the FDA announced an update to the Influenza Diagnostic Tests web page, indicating that LDTs for Highly Pathogenic Avian Influenza (HPAI) offered by clinical laboratories that are certified under Clinical Laboratory Improvement Amendments (CLIA) and qualified to perform high-complexity testing currently fall under the FDA’s general enforcement discretion approach for LDTs. https://t.co/k1MzWJNDX4
On Thursday, the FDA announced an update about the ongoing evaluation of quality and performance issues related to plastic syringes made in China. https://t.co/qVm8Wkglea
On Thursday, the FDA announced a public workshop titled Accreditation Scheme for Conformity Assessment (ASCA) and Use of Chemical Analysis to Support Biocompatibility of Medical Devices that will be held on Wednesday, November 6, 2024. https://t.co/oOCPUaLKGn
On Thursday, the FDA published the FDA Voices “Catching Up with Califf: Men’s Health is Falling Behind – Some Thoughts About Why,” by @DrCaliff_FDA. https://t.co/8Yeq3r2Q6K
On Thursday, the FDA authorized the marketing of seven e-cigarette products in the United States through the premarket tobacco product application pathway. https://t.co/tkup7PpcxU
On Wednesday, July 17, the FDA published the FDA Voices: “FDA Rare Disease Innovation Hub to Enhance and Advance Outcomes for Patients,” by Patrizia Cavazzoni, M.D., director of the Center for Drug Evaluation and Research and Peter Marks, M.D., Ph.D., director of the Center for Biologics Evaluation and Research. https://t.co/2CXjmU1SxK
On Tuesday, July 16, the FDA published the FDA Voices: “From Awareness to Action: Tackling the Rising Burden of Common Chronic Diseases,” by @DrCaliff_FDA. https://t.co/U6dpmjsuTO
On Tuesday, July 16, the FDA issued a draft guidance for industry, “Pediatric Inflammatory Bowel Disease: Developing Drugs for Treatment,” to help sponsors in the clinical development of drugs to treat pediatric patients with inflammatory bowel disease (IBD). https://t.co/oLdwl7fFv1
On Thursday, July 25, from 12-4 p.m. ET, the FDA will host a virtual public meeting to discuss the Home as a Health Care Hub initiative. https://t.co/psyQIQmUDb
DP Clinical, Inc., a Contract Research Organization; today announced that July 1st, 2019, marked the company’s 25-year anniversary providing CRO services to pharma, biotech, & medical device companies.
https://t.co/UTAIL4tHeP
We’re looking for pairs of loved ones who have been affected by breast cancer to be a part of an exciting Breast Cancer Awareness Month campaign with one of our fantastic retail partners. Interested?
📧 [email protected] by Fri 15 June & we’ll send you more info.
participation in health research allows us to make discoveries, understand care better and provide better services! 😀 @VCHResearch#SCI https://t.co/XpzPCLTAvI
We were able to share our new look & logo at the @ASIA_spine 2018 conference last week in MN. It was great to see old friends and make new ones! Thank ASIA for a great conference! #SCI
We have a NEW look but still the SAME commitment to "Partnering in Success" with you. Check out our new website and social media and let us know what you think! https://t.co/0YRtM2feMI
Today on the day we turn our focus on the 7000 Rare Diseases that people all over the world are suffering and struggling with. We offer our gratitude and thanks to the researcher, clinicians, patients and caregivers hoping for a cure.
In recognition of #RareDiseaseDay, we will share 2017 highlights of advances and drug approvals in treating #RareDisease. Many of these approvals were first-ever. Stay tuned all day and learn more about rare diseases here: https://t.co/gMHqEIlxGe